Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.
about
Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsJDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cellsmiRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In PatientsThe Drosophila MAPK p38c regulates oxidative stress and lipid homeostasis in the intestineKahweol from Coffee Induces Apoptosis by Upregulating Activating Transcription Factor 3 in Human Colorectal Cancer Cells.Genomic and proteomic analysis of transcription factor TFII-I reveals insight into the response to cellular stress.A systems biology approach to the global analysis of transcription factors in colorectal cancer.Anti-cancer activity of Ginger (Zingiber officinale) leaf through the expression of activating transcription factor 3 in human colorectal cancer cellsTolfenamic Acid Suppresses Inflammatory Stimuli-Mediated Activation of NF-κB Signaling.The induction of activating transcription factor 3 (ATF3) contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells.TNF-α induces cytosolic phospholipase A2 expression in human lung epithelial cells via JNK1/2- and p38 MAPK-dependent AP-1 activation.ATF3 Mediates Anti-Cancer Activity of Trans-10, cis-12-Conjugated Linoleic Acid in Human Colon Cancer Cells.Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cellsDamnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cellsATF2 - at the crossroad of nuclear and cytosolic functions.Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells.COX inhibitors directly alter gene expression: role in cancer prevention?Naringenin-Mediated ATF3 Expression Contributes to Apoptosis in Human Colon Cancer.In Vitro Anticancer Activity of Phlorofucofuroeckol A via Upregulation of Activating Transcription Factor 3 against Human Colorectal Cancer CellsApoptotic effect of tolfenamic acid on MDA-MB-231 breast cancer cells and xenograft tumors.A Taiwanese Propolis Derivative Induces Apoptosis through Inducing Endoplasmic Reticular Stress and Activating Transcription Factor-3 in Human Hepatoma Cells.The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy.Guanidine Alkaloids from the Marine Sponge Monanchora pulchra Show Cytotoxic Properties and Prevent EGF-Induced Neoplastic Transformation in Vitro.The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines.Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand A domain.Activating transcription factor 3 and the nervous system.Characteristics of human CD34+ cells exposed to ionizing radiation under cytokine-free conditions.Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cells.Elevated cJUN expression and an ATF/CRE site within the ATF3 promoter contribute to activation of ATF3 transcription by the amino acid response.Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion.Vitex rotundifolia Fruit Extract Induces Apoptosis Through the Downregulation of ATF3-Mediated Bcl-2 Expression in Human Colorectal Cancer Cells.EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer.Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3.
P2860
Q27004250-FAA711B5-7332-47F8-A86B-727BE2E41F88Q28265314-A86CBD78-99DB-41D8-8E31-7AC538547D90Q28392422-74CDAFBC-C051-45E9-8AEB-8A15002669D1Q28543215-A45024A2-19B2-433A-A7B7-9471EA782D27Q33655934-FDB2DCC3-F70F-4128-BCA2-D59CC3E29806Q33843133-D74EED4D-B254-48E5-AD26-C971C8C027FCQ34361370-9D120E48-0FB7-4E61-AA4D-6A40395C332AQ34409934-AAF118C6-D207-46EE-8904-1629E0CC63A9Q34865096-D71CADEF-3C03-42CE-A44B-FF5E926128E3Q34995975-77BB1496-00AF-45BD-A698-96EBA1E5EED5Q34998514-1BA842B3-F041-438E-8965-CCEC31DD885AQ35161272-F8959BA4-E61F-4898-8F36-B63AC05615A0Q35403130-1FBDE1C2-8CB4-4BA3-9587-AB214A2D53A0Q35569185-9FBD5014-C52E-441E-AD2E-997D9FD8DA9AQ36211955-8D377758-576E-4FCD-95D2-FED865F9D0E3Q36430758-D385907E-912C-4080-8B94-13CA6E81E466Q36635956-5856A9F5-70B3-4DC3-8554-9BCBF91387F3Q36640406-5EB914F7-0940-4938-80DA-3E54539453E1Q36847345-F479712A-DF94-4295-80DC-984FFEDD3FA6Q36993540-6A4C9597-BA02-4858-BAD5-37DD2CBE2E47Q37270468-DB41AAA7-A77D-4ABE-9F30-B4DC93DB649DQ37374999-DA1B9A5D-FDCC-4281-B430-168B1A3A7A21Q38719571-BEE294A2-D6D0-4F78-A33F-8E219747D926Q38757470-F0942A42-1112-42E4-BBF2-6715FBA114A3Q38927458-2CAD2749-CB71-428A-A1B7-90A41F1F5650Q39310806-9518E5CF-7870-4317-A63A-EADEBAF5B88BQ39438559-7B099D3E-0839-4E1C-A634-B5E3B83F0591Q39450922-6E2F0F9D-89E2-448E-B141-A6B196E341BAQ41098388-4AF50FB4-9EF8-42C8-BF7B-A46C9BE809A7Q41175928-93516B66-BF5C-48A9-BE9F-81FDC23DB8A1Q41872927-94E4468C-820E-4B9E-88A3-5723B89B268FQ42156568-A85DD9C2-007B-42E6-8F22-5301D7A19682Q42206973-C4AC44CC-BD91-41B2-B425-971C64CD30C8Q46372441-5E0A06CA-B35D-4319-9675-8994E7E0A592Q47122770-E8D1D3AC-7D16-4BC8-B6A2-A59BB5B31C4CQ51052506-E684CFE4-649D-4569-897E-59E08EFCB187
P2860
Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activating transcription facto ...... ssion via MAP kinase pathways.
@ast
Activating transcription facto ...... ssion via MAP kinase pathways.
@en
Activating transcription factor 2
@nl
type
label
Activating transcription facto ...... ssion via MAP kinase pathways.
@ast
Activating transcription facto ...... ssion via MAP kinase pathways.
@en
Activating transcription factor 2
@nl
prefLabel
Activating transcription facto ...... ssion via MAP kinase pathways.
@ast
Activating transcription facto ...... ssion via MAP kinase pathways.
@en
Activating transcription factor 2
@nl
P2093
P2860
P356
P1433
P1476
Activating transcription facto ...... ssion via MAP kinase pathways.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2010.251
P407
P577
2010-06-28T00:00:00Z
P5875
P6179
1002786878